Table 3. Risk of developing major depression and any depressive disorder among women with symptomatic menopausal transition (n = 5837) compared to the control group (n = 23,348).
Major depression | Any depressive disorder | |||||
HR | 95%CI | p | HR | 95%CI | p | |
Symptomatic menopausal transition | 2.18 | 1.79∼2.65 | <0.001 | 2.34 | 2.08∼2.63 | <0.001 |
Age at enrollment | 0.99 | 0.98∼1.00 | 0.057 | 0.99 | 0.98∼1.00 | 0.006 |
Medical comorbidities during the whole follow-up period | ||||||
Diabetes mellitus | 1.13 | 0.90∼1.41 | 0.289 | 1.11 | 0.97∼1.27 | 0.125 |
Congestive heart failure | 1.27 | 0.82∼1.98 | 0.285 | 1.35 | 1.04∼1.75 | 0.026 |
Chronic renal diseases | 1.18 | 0.86∼1.64 | 0.311 | 1.16 | 0.96∼1.41 | 0.132 |
Liver diseases | 1.18 | 0.94∼1.47 | 0.163 | 1.19 | 1.03∼1.36 | 0.015 |
Rheumatological diseases | 1.04 | 0.607∼1.78 | 0.891 | 1.33 | 0.99∼1.79 | 0.057 |
Cerebrovascular disease | 1.74 | 1.35∼2.24 | <0.001 | 1.77 | 1.52∼2.07 | <0.001 |
Coronary artery disease | 1.23 | 0.95∼1.60 | 0.121 | 1.35 | 1.15∼1.57 | <0.001 |
Residence location | ||||||
Northern | 1 | – | – | 1 | – | – |
Middle | 0.91 | 0.67∼1.25 | 0.568 | 1.21 | 1.01∼1.44 | 0.039 |
Southern | 1.41 | 1.12∼1.77 | 0.004 | 1.51 | 1.32∼1.74 | <0.001 |
Eastern | 1.72 | 1.12∼2.64 | 0.014 | 1.19 | 0.88∼1.60 | 0.260 |
Level of urbanization | ||||||
1 (most urban) | 1 | – | – | 1 | – | – |
2 | 0.89 | 0.69∼1.13 | 0.333 | 0.97 | 0.83∼1.12 | 0.641 |
3 | 0.88 | 0.64∼1.19 | 0.394 | 0.79 | 0.65∼0.95 | 0.014 |
4 | 0.84 | 0.60∼1.17 | 0.291 | 0.85 | 0.70∼1.04 | 0.112 |
5 (most rural) | 0.67 | 0.45∼1.01 | 0.055 | 0.75 | 0.59∼0.96 | 0.020 |
Income-related insured amount | ||||||
<20,000NTD/month | 1 | – | – | 1 | – | – |
20,000∼39,999NTD/month | 0.81 | 0.66∼1.01 | 0.059 | 0.86 | 0.76∼0.98 | 0.026 |
≥40,000NTD/month | 0.63 | 0.42∼0.94 | 0.023 | 0.84 | 0.67∼1.05 | 0.841 |
Major depression: 296.2X and 296.3X.
Any depressive disorder: 296.2X, 296.3X, 300.4, and 311.
HR: hazard ratio; 95% CI: 95% confidence interval.